A H Anton. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » Abnormalities, Drug-InducedBlood Proteins/metabolismDrug SynergismEscherichia coli/drug effectsFemaleFetusHumansInfant, NewbornKineticsMaternal-Fetal Exchange/drug effectsPhenylbutazone/pharmacologyPregnancyProtein Binding/drug effectsSerum Albumin/metabolismSulfadiazineSulfamethoxypyridazine/bloodSulfathiazoles/bloodSulfinpyrazone/pharmacologySulfisoxazole/bloodSulfonamides/adverse effectsSulfonamides/bloodSulfonamides/pharmacology
Substances: See more » Blood ProteinsSerum AlbuminSulfathiazolesSulfonamidesSulfadiazineSulfisoxazolePhenylbutazoneSulfamethoxypyridazineSulfinpyrazone
Year: 1973 PMID: 4588442 DOI: 10.1111/j.1749-6632.1973.tb20490.x
Source DB: PubMed Journal: Ann N Y Acad Sci ISSN: 0077-8923 Impact factor: 5.691